Innovative Cancer Immunotherapy Targets Tumors Without Weakening Immune System

Researchers explore new approaches to overcome cancer's ability to evade the immune system.

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

The landscape of cancer treatment is rapidly evolving, with researchers exploring innovative immunotherapy approaches that harness the body's own defenses. While existing immunotherapies have proven effective for some patients, scientists are working to refine and expand their capabilities, including strategies to reawaken exhausted T cells, target cancer cell glycans, and even utilize bacteria to directly kill tumors.

Why it matters

These new immunotherapy approaches aim to overcome the key challenge of cancer's ability to evade the immune system, which has limited the effectiveness of traditional treatments. By developing more targeted and personalized therapies, researchers hope to improve outcomes for cancer patients while minimizing harmful side effects.

The details

Researchers are exploring several innovative immunotherapy strategies, including reawakening 'exhausted' T cells that have become impaired by prolonged exposure to cancer, as well as a novel approach that targets the complex carbohydrate chains (glycans) found on the surface of cancer cells. Additionally, scientists in Japan have unveiled a bacteria-based therapy that can directly kill cancer cells without involving the immune system, representing a radical departure from traditional immunotherapy.

  • The research on these new immunotherapy approaches has been ongoing, with several key developments reported in 2025 and 2026.

The players

Dr. Michelle Krogsgaard

An immunologist at NYU Langone Health's Perlmutter Cancer Center who is studying how T cells identify cancer cells and how this process can be improved to enhance the immune system's ability to target tumors.

Michael Demetriou

The lead researcher behind the development of GlyTR, a new class of immunotherapeutics that target cancer cell glycans, at the University of California, Irvine.

Got photos? Submit your photos here. ›

What they’re saying

“We're hoping to get deep molecular insights into how T-cell therapies work so we can develop treatments that are better, safer, and potentially tailored to each patient.”

— Dr. Michelle Krogsgaard, Immunologist

“This potentially could be one treatment to kill virtually all cancers.”

— Michael Demetriou, Researcher

What’s next

Researchers will continue to refine and test these new immunotherapy approaches, with the goal of bringing more effective and personalized cancer treatments to patients.

The takeaway

The development of innovative immunotherapies that can overcome cancer's ability to evade the immune system represents a significant advancement in the fight against this disease, offering hope for more targeted, safer, and personalized cancer treatments in the future.